Table 1.
Demographics and underlying conditions of patients with COVID-19 examined for Mucorales.
| No. Patients (%) | |
|---|---|
| Total | 100 (100) |
| Type of specimen from respiratory tract: BAL, TS, BS | 92 (92), 6 (6.0), 2 (2.0) |
| Filamentous fungi-specific culture Ɨ performed/positive for Mucorales | 100 (100.0)/0 |
| Mucorales PCR # performed/positive | 100 (100)/1 (1.0) |
| Hospitalized | 100 (100) |
| Treatment on intensive care unit | 100 (100) |
| Mean age (years) | 58 |
| Male | 71 (71) |
| Invasive mechanical ventilation | 96 (96) |
| ECMO | 50 (50) |
| Use of Steroids | 59 (59) |
| Mortality | 59 (59) |
| Underlying conditions | |
| Cardiovascular disease | 35 (35) |
| Diabetes | 27 (27) |
| Pulmonary disease | 11 (11) |
| Cancer | 4 (4.0) |
| Other (Crohn’s disease) | 1 (1.0) |
| None | 48 (48) |
| One underlying condition | 31 (31) |
| Two underlying conditions | 17 (17) |
| >two underlying conditions | 4 (4.0) |
BAL, bronchoalveolar lavage fluid; TS, tracheal secretion; BS, bronchial secretion; ECMO, extracorporeal membrane oxygenation; Ɨ Malt Extract agar (Oxoid, Wesel, Germany); # MucorGenius (PathoNostics, Maastricht, The Netherlands).